Rabeximod (ROB803; ROB-803) is a novel and potent immunomodulator for the treatment of moderate or severe active rheumatoid arthritis. It is currently undergoing phase II clinical trials. It reduced the arthritis by preventing the TLR2 and TLR4 mediated inflammatory cells activation.

纯度：≥98%

CAS：872178-65-9